Literature DB >> 29555351

Mycoplasma pneumoniae induces allergy by producing P1-specific immunoglobulin E.

Qing Ye1, Jian-Hua Mao2, Qiang Shu2, Shi-Qiang Shang2.   

Abstract

BACKGROUND: Our previous study found that most Mycoplasma pneumoniae (MP) pneumonia (MPP)patients had elevated serum total immunoglobulin E (IgE) levels.
OBJECTIVE: To determine components of MP that can cause an IgE increase in children, and to clarify its specific mechanism.
METHODS: The components of MP cells were isolated by serum IgE from patients with MP pneumonia. These components obtained through the prokaryotic expression were used as allergens to detect the proportion of allergen-specific IgE produced in MPP patients, and the clinical characteristics and related immune parameters of these patients who produced this allergen-specific IgE were also analyzed. In addition, a cell experiment was used to verify the biological effect of these components in vitro.
RESULTS: P1-specific IgE was detected in serum of MPP children. An approximately 24-kDa polypeptide of P1 protein was obtained through prokaryotic expression purified by nickel agarose affinity chromatography. Approximately 9.2% of MPP patients produced IgE against this polypeptide of P1 protein, which was more likely to be produced in MPP patients with no history of allergies or family history of allergy-related diseases. P1-specific IgE-positive MPP patients had more severe clinical symptoms, with excessive secretion of interleukin (IL)-4 and IL-5 and overdifferentiation of Th0 cells into Th2 cells. Tests also demonstrated that the P1 protein stimulated excessive secretion of IL-4 and IL-5 in peripheral blood mononuclear cells from the peripheral blood of healthy donors.
CONCLUSION: Mycoplasma pneumoniae is not only an infectious agent but also an allergen for certain individuals. The P1 protein of MP can induce the production of P1-specific IgE.
Copyright © 2018 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29555351     DOI: 10.1016/j.anai.2018.03.014

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  3 in total

1.  Impact of atopy on the severity and extrapulmonary manifestations of childhood Mycoplasma pneumoniae pneumonia.

Authors:  Zhihua Wang; Jian Sun; Yan Liu; Yushui Wang
Journal:  J Clin Lab Anal       Date:  2019-03-29       Impact factor: 2.352

2.  Increased Total Serum Immunoglobulin E Is Likely to Cause Complications of Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Lili Zhou; Yuan Li; Zhufei Xu; Xuyun Peng; Xiaoyan Gong; Lin Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-11-24       Impact factor: 5.293

3.  Mycoplasma pneumonia Infection Is Associated With an Increased Risk of Systemic Lupus Erythematosus: A Nationwide, Retrospective Cohort Study.

Authors:  Kuo-An Chu; Ting-Yun Ou; Wei-Hsin Hung; Jie Sung; Weishan Chen; Cheng-Li Lin; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Microbiol       Date:  2022-04-21       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.